Logo image of ALKEY.PA

KEYRUS (ALKEY.PA) Stock Fundamental Analysis

EPA:ALKEY - Euronext Paris - Matif - FR0004029411 - Common Stock - Currency: EUR

7.5  -0.04 (-0.53%)

Fundamental Rating

1

Taking everything into account, ALKEY scores 1 out of 10 in our fundamental rating. ALKEY was compared to 75 industry peers in the IT Services industry. Both the profitability and financial health of ALKEY have multiple concerns. ALKEY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALKEY had negative earnings in the past year.
In the past year ALKEY had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALKEY reported negative net income in multiple years.
ALKEY had a positive operating cash flow in each of the past 5 years.
ALKEY.PA Yearly Net Income VS EBIT VS OCF VS FCFALKEY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M 50M

1.2 Ratios

ALKEY's Return On Assets of -0.54% is on the low side compared to the rest of the industry. ALKEY is outperformed by 62.67% of its industry peers.
ALKEY's Return On Equity of -4.16% is on the low side compared to the rest of the industry. ALKEY is outperformed by 64.00% of its industry peers.
ALKEY has a worse Return On Invested Capital (5.44%) than 62.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALKEY is significantly below the industry average of 10.94%.
Industry RankSector Rank
ROA -0.54%
ROE -4.16%
ROIC 5.44%
ROA(3y)1.12%
ROA(5y)0.22%
ROE(3y)9.2%
ROE(5y)2.91%
ROIC(3y)5.58%
ROIC(5y)4.54%
ALKEY.PA Yearly ROA, ROE, ROICALKEY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

ALKEY's Profit Margin has declined in the last couple of years.
ALKEY has a Operating Margin (3.95%) which is comparable to the rest of the industry.
ALKEY's Operating Margin has been stable in the last couple of years.
ALKEY has a Gross Margin of 63.30%. This is comparable to the rest of the industry: ALKEY outperforms 52.00% of its industry peers.
ALKEY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.95%
PM (TTM) N/A
GM 63.3%
OM growth 3Y16.42%
OM growth 5Y0.5%
PM growth 3YN/A
PM growth 5Y-21.83%
GM growth 3Y-2.32%
GM growth 5Y-0.01%
ALKEY.PA Yearly Profit, Operating, Gross MarginsALKEY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALKEY is destroying value.
ALKEY has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALKEY has been increased compared to 5 years ago.
Compared to 1 year ago, ALKEY has a worse debt to assets ratio.
ALKEY.PA Yearly Shares OutstandingALKEY.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ALKEY.PA Yearly Total Debt VS Total AssetsALKEY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

ALKEY has an Altman-Z score of 1.61. This is a bad value and indicates that ALKEY is not financially healthy and even has some risk of bankruptcy.
ALKEY has a worse Altman-Z score (1.61) than 66.67% of its industry peers.
ALKEY has a debt to FCF ratio of 4.61. This is a neutral value as ALKEY would need 4.61 years to pay back of all of its debts.
With a Debt to FCF ratio value of 4.61, ALKEY perfoms like the industry average, outperforming 45.33% of the companies in the same industry.
ALKEY has a Debt/Equity ratio of 1.77. This is a high value indicating a heavy dependency on external financing.
ALKEY has a Debt to Equity ratio of 1.77. This is in the lower half of the industry: ALKEY underperforms 76.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.77
Debt/FCF 4.61
Altman-Z 1.61
ROIC/WACC0.92
WACC5.92%
ALKEY.PA Yearly LT Debt VS Equity VS FCFALKEY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.00 indicates that ALKEY may have some problems paying its short term obligations.
ALKEY has a Current ratio of 1.00. This is in the lower half of the industry: ALKEY underperforms 65.33% of its industry peers.
ALKEY has a Quick Ratio of 1.00. This is a bad value and indicates that ALKEY is not financially healthy enough and could expect problems in meeting its short term obligations.
ALKEY's Quick ratio of 1.00 is on the low side compared to the rest of the industry. ALKEY is outperformed by 62.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
ALKEY.PA Yearly Current Assets VS Current LiabilitesALKEY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

1

3. Growth

3.1 Past

The earnings per share for ALKEY have decreased strongly by -136.51% in the last year.
Measured over the past years, ALKEY shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.02% on average per year.
Looking at the last year, ALKEY shows a decrease in Revenue. The Revenue has decreased by -2.62% in the last year.
The Revenue has been growing slightly by 6.27% on average over the past years.
EPS 1Y (TTM)-136.51%
EPS 3YN/A
EPS 5Y-17.02%
EPS Q2Q%-179.75%
Revenue 1Y (TTM)-2.62%
Revenue growth 3Y12.38%
Revenue growth 5Y6.27%
Sales Q2Q%-4.62%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALKEY.PA Yearly Revenue VS EstimatesALKEY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
ALKEY.PA Yearly EPS VS EstimatesALKEY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALKEY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKEY.PA Price Earnings VS Forward Price EarningsALKEY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALKEY is valued a bit cheaper than 61.33% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALKEY is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.34
EV/EBITDA 7.96
ALKEY.PA Per share dataALKEY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALKEY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KEYRUS

EPA:ALKEY (3/7/2025, 7:00:00 PM)

7.5

-0.04 (-0.53%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.76%
Inst Owner ChangeN/A
Ins Owners85.52%
Ins Owner ChangeN/A
Market Cap129.60M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP-24.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF 6.34
P/OCF 5.75
P/B 3.06
P/tB N/A
EV/EBITDA 7.96
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.18
FCFY15.78%
OCF(TTM)1.31
OCFY17.4%
SpS20.93
BVpS2.45
TBVpS-3.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -4.16%
ROCE 9.01%
ROIC 5.44%
ROICexc 7.43%
ROICexgc 45.79%
OM 3.95%
PM (TTM) N/A
GM 63.3%
FCFM 5.66%
ROA(3y)1.12%
ROA(5y)0.22%
ROE(3y)9.2%
ROE(5y)2.91%
ROIC(3y)5.58%
ROIC(5y)4.54%
ROICexc(3y)8.55%
ROICexc(5y)6.99%
ROICexgc(3y)70.15%
ROICexgc(5y)55.42%
ROCE(3y)9.25%
ROCE(5y)7.53%
ROICexcg growth 3Y8.83%
ROICexcg growth 5Y12.15%
ROICexc growth 3Y17.23%
ROICexc growth 5Y-1.56%
OM growth 3Y16.42%
OM growth 5Y0.5%
PM growth 3YN/A
PM growth 5Y-21.83%
GM growth 3Y-2.32%
GM growth 5Y-0.01%
F-Score4
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 1.77
Debt/FCF 4.61
Debt/EBITDA 3.28
Cap/Depr 24.73%
Cap/Sales 0.58%
Interest Coverage 2.21
Cash Conversion 98.96%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 1.61
F-Score4
WACC5.92%
ROIC/WACC0.92
Cap/Depr(3y)26.06%
Cap/Depr(5y)31.55%
Cap/Sales(3y)0.76%
Cap/Sales(5y)1.11%
Profit Quality(3y)409.78%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.51%
EPS 3YN/A
EPS 5Y-17.02%
EPS Q2Q%-179.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.62%
Revenue growth 3Y12.38%
Revenue growth 5Y6.27%
Sales Q2Q%-4.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.59%
EBIT growth 3Y30.83%
EBIT growth 5Y6.81%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.32%
FCF growth 3Y-25.62%
FCF growth 5YN/A
OCF growth 1Y48.1%
OCF growth 3Y-25.51%
OCF growth 5Y223.07%